Becton Dickinson & Co.’s stock fell more than 15% on Thursday toward its worst one-day loss in 26 years after the medical-products maker said global cuts in research funding are impacting its research ...

Becton Dickinson (BDX) has been under pressure, with the share price showing a 0.2% decline over the past day, about 4.6% ...

As the healthcare industry continues to rebound from global disruptions, companies like Becton, Dickinson, and Company (NYSE:BDX) are reporting robust financial performances that highlight their ...

Becton Dickinson (BDX) came out with quarterly earnings of $3.68 per share, beating the Zacks Consensus Estimate of $3.42 per share. This compares to earnings of $3.5 per share a year ago. These ...

Aug 7 (Reuters) - Becton Dickinson (BDX.N), opens new tab raised its forecast for annual profit on Thursday, after beating Wall Street estimates for third-quarter profit and sales on strong demand for ...

Becton Dickinson (NYSE:BDX) received FDA clearance for its Surgiphor 1000mL antimicrobial irrigation system, expanding its ...

Detailed price information for Becton Dickinson and Company (BDX-N) from The Globe and Mail including charting and trades.

6 analysts have shared their evaluations of Becton Dickinson (NYSE:BDX) during the recent three months, expressing a mix of bullish and bearish perspectives. The following table provides a quick ...

We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to take a look at where Becton, Dickinson and Company (NYSE:BDX) stands against ...

Becton Dickinson was hit with a patent infringement lawsuit on Oct. 27 in New Jersey District Court over its PowerPort line of implantable vascular access devices. The action, brought by FisherBroyles ...

Company's stock falls 15% after it says its research-instrument business has been impacted Becton Dickinson & Co.'s stock fell more than 15% on Thursday toward its worst one-day loss in 26 years after ...